BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events
X-WR-CALDESC:Events for 
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200430T100000
DTEND;TZID=America/New_York:20200430T110000
DTSTAMP:20260418T034058
CREATED:20200420T201307Z
LAST-MODIFIED:20200420T201307Z
UID:1756-1588240800-1588244400@www.mdtechcouncil.com
SUMMARY:Emergency Market Authorization of COVID-19 IVDs
DESCRIPTION:Please join Amarex for a complimentary webinar to review insights into the Emergency Market Authorization of COVID-19 IVDs. It will cover the emergency authorization applications for the E.U.\, the U.S.\, Asia\, Australia and the World Health Organization. \nThis webinar is being offered twice to accommodate our clients in the E.U.\, the U.S. and Asia. \nLearn from industry experts: \n\nRobyn Meurant\, Executive Director at NSF International. Before joining NSF\, Robyn acted both as a professional officer and an advisor to the WHO and assisted with the development of the EUL for IVDs.\nChia-hua Maggie Ho\, D. Phil.\, COO of Amarex Clinical Research\, LLC\, an NSF International Company. Dr. Ho specializes in APAC regulatory submission\, clinical operations\, business development and client services for the Pan-Pacific region.\n\nRegister now for this complimentary webinar. \nPlease send your questions to healthsciences@nsf.org. \n  \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/emergency-market-authorization-of-covid-19-ivds/
LOCATION:Webinar\, United States
GEO:37.09024;-95.712891
CATEGORIES:Life Science
END:VEVENT
END:VCALENDAR